Treatment for Pediatric Non-Alcoholic Fatty Liver Disease with Polylactose: A Novel Prebiotic
This study will test whether or not a prebiotic, polylactose, is safe and effective in reducing fat depositions in the liver in individuals who have been diagnosed with non-alcoholic fatty liver disease.
Obesity, Adolescent, Obesity, Childhood
Justin Ryder - firstname.lastname@example.org
NCT04100109See this study on ClinicalTrials.gov